Standard Specimen Reference Set: Breast Cancer and Imaging
- Abbreviated Name
- BRS-I
- Lead Investigator
- Marks, Jeffrey — Duke University Medical Center
- Coordinating Investigator
- Feng, Ziding — Fred Hutchinson Cancer Center
- Involved Investigators
-
- Feng, Ziding — Fred Hutchinson Cancer Center
- Crichton, Dan — NASA Jet Propulsion Laboratory
- Heine, John — H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Lokshin, Anna — University of Pittsburgh Cancer Institute
- Tang, Cha-Mei — Creatv MicroTech Inc.
- Anderson, Karen — Arizona State University
- Marks, Jeffrey — Duke University Medical Center
- Diaz-Mayoral, Norma — Frederick National Laboratory for Cancer Research
- Srivastava, Sudhir — National Cancer Institute
- Esserman, Laura J. — University of California at San Francisco
- Engstrom, Paul — Fox Chase Cancer Center
Abstract
The primary objective of this study is to assemble a well-characterized set of blood specimens and images to test biomarkers that, in conjunction with mammography, can detect and discriminate breast cancer. These samples will be divided to provide “sets” of specimens that can be tested in a number of different laboratories. Since tests will be performed on the same sets of samples, the data will be directly comparable and decisions regarding which biomarker or set of biomarkers have value in breast cancer detection can be made. These sets will reside at a National Cancer Institute facility at Frederick, MD.
Aims
see Objectives
Analytic Method
N/A
Outcome
The primary objective of this study is to assemble a well-characterized set of blood specimens and images to test biomarkers that, in conjunction with mammography, can detect and discriminate breast cancer. These samples will be divided to provide “sets” of specimens that can be tested in a number of different laboratories. Since tests will be performed on the same sets of samples, the data will be directly comparable and decisions regarding which biomarker or set of biomarkers have value in breast cancer detection can be made. These sets will reside at a National Cancer Institute facility at Frederick, MD.
Publications
Biomarkers
- No biomarkers available at this time for this protocol.
Data Collections
There are 3 collections of data that have not yet been made public. Logging in may you give you access to the names of the non-public data collections.
Team Project
- Start Date
- Jun 2 2006
- Estimated Finish Date
- Mar 31 2021
- Protocol ID
- 121
- Protocol Type
- Reference Set
- Fields of Research
-
- Other
- Collaborative Group
- Breast and Gynecologic Cancers Research Group
- Cancer Types
-
- Malignant neoplasm of breast